NanoMedical Systems

About NanoMedical Systems

NanoMedical Systems develops novel subcutaneous implantable devices using its nStrada nanofluidics platform for sustained drug delivery. The company designs implants capable of long-term, constant release of a wide range of therapeutics, including small molecules, peptides, and proteins, with no power or moving parts required. Its nStrada platform leverages semiconductor manufacturing methods and biocompatible materials to provide tunable nanochannel-based dosing for weeks to over a year, aiming to improve upon polymer-based implants. The company is based in Austin, Texas, and emphasizes ISO 9001 quality and scalable manufacturing for chronic therapies.